Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine efficacy and safety for uncomplicated falciparum malaria in Senegal
ACTRN12610001023044Phase 4Completed
- Sponsor
- Ministry of Health and Social Action
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artemether, lumefantrine, artesunate and amodiaquine in malaria and Malaria (2 arms), sponsored by Ministry of Health and Social Action. Primary endpoints: Treatment failure rate and Adverse event rate in artemether-lumefantrine group. Started Nov 2010; status: completed.
02
Drugs
artemetherlumefantrineartesunateamodiaquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12610001023044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001023044.